Virtus LifeSci Valuation Overview

BBP -- USA Etf  

USD 36.01  0.82  2.23%

Virtus LifeSci Biotech has current Real Value of $34.26 per share. The regular price of the etf is $36.01. At this time the etf appears to be over valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 12, Net Asset of 28.81M and Price to Earning of 18.03X as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Products ETF is fourth largest ETF in price to earning as compared to similar ETFs. It is the top ETF in price to sales as compared to similar ETFs fabricating about  0.31  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for Virtus LifeSci Biotech Products ETF is roughly  3.22 

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries

Over Valued
December 18, 2018
36.01
Market Value
34.26
Real Value
Target Odds
  
42.66
Upside
Virtus LifeSci is not too volatile asset. Calculation of real value of Virtus LifeSci Biotech is based on 2 months time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Search macroaxis.com